|
|
||||||||
The Journal of Immunology, Vol 156, Issue 5 1714-1721, Copyright © 1996 by American Association of Immunologists
ARTICLES |
JS Duke-Cohan, C Morimoto, JA Rocker and SF Schlossman
Division of Tumor Immunology, Dana Farber Cancer Institute, Boston, MA 02115, USA.
This study demonstrates that the 175-kDa form of dipeptidyl peptidase IV (DPPIV) found in normal human serum is identical with a similarly- sized Ag, DPPT-L, found to be rapidly expressed on the surface of activated T cells. As activation progresses, the expression of DPPT-L reaches a peak on day 3, after which expression falls, whereas expression of the 105-kDa CD26/DPPIV detected by the mAb 1F7 increases, as does the ability to bind adenosine deaminase. The loss of DPPT-L from the surface of activated T cells correlates exactly with the appearance of DPPT-L and DPPIV activity in serum-free tissue culture medium. The release of DPPIV was generally greater from CD4+ cells than from CD8+ T cells, and within the CD4+ subset, the CD45RO+ subset was the major source, which correlated with surface expression before culture. We show that the DPPIV released from activated T cells is antigenically, biochemically, and enzymatically similar to DPPIV circulating in the serum and is distinct from the DPPIV activity of 105- kDa CD26. The T cell-released DPPIV is able to function as a costimulating molecule for the response to the recall Ag, tetanus toxoid, at levels similar to those at which recombinant soluble CD26 and serum DPPIV exhibit costimulatory function, suggesting that the released DPPIV may serve an important immunoregulatory function in vivo, both locally and within the systemic circulation.
This article has been cited by other articles:
![]() |
D. D'Alessio, W. Lu, W. Sun, S. Zheng, Q. Yang, R. Seeley, S. C. Woods, and P. Tso Fasting and postprandial concentrations of GLP-1 in intestinal lymph and portal plasma: evidence for selective release of GLP-1 in the lymph system Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2163 - R2169. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W. Khwaja, J. S. Duke-Cohan, D. J. Brat, and E. G. Van Meir Attractin Is Elevated in the Cerebrospinal Fluid of Patients with Malignant Astrocytoma and Mediates Glioma Cell Migration. Clin. Cancer Res., November 1, 2006; 12(21): 6331 - 6336. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wrenger, J. Faust, D. Friedrich, T. Hoffmann, R. Hartig, U. Lendeckel, T. Kahne, A. Thielitz, K. Neubert, and D. Reinhold Attractin, a dipeptidyl peptidase IV/CD26-like enzyme, is expressed on human peripheral blood monocytes and potentially influences monocyte function J. Leukoc. Biol., September 1, 2006; 80(3): 621 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Bjelke, J. Christensen, S. Branner, N. Wagtmann, C. Olsen, A. B. Kanstrup, and H. B. Rasmussen Tyrosine 547 Constitutes an Essential Part of the Catalytic Mechanism of Dipeptidyl Peptidase IV J. Biol. Chem., August 13, 2004; 279(33): 34691 - 34697. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Korosi, C. H.S. McIntosh, R. A. Pederson, H.-U. Demuth, J. F. Habener, R. Gingerich, J. M. Egan, D. Elahi, and G. S. Meneilly Effect of Aging and Diabetes on the Enteroinsular Axis J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2001; 56(9): M575 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Elhabazi, S. Delaire, A. Bensussan, L. Boumsell, and G. Bismuth Biological Activity of Soluble CD100. I. The Extracellular Region of CD100 Is Released from the Surface of T Lymphocytes by Regulated Proteolysis J. Immunol., April 1, 2001; 166(7): 4341 - 4347. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Duke-Cohan, J. Gu, D. F. McLaughlin, Y. Xu, G. J. Freeman, and S. F. Schlossman Attractin (DPPT-L), a member of the CUB family of cell adhesion and guidance proteins, is secreted by activated human T lymphocytes and modulates immune cell interactions PNAS, September 15, 1998; 95(19): 11336 - 11341. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shioda, H. Kato, Y. Ohnishi, K. Tashiro, M. Ikegawa, E. E. Nakayama, H. Hu, A. Kato, Y. Sakai, H. Liu, et al. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha ) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage PNAS, May 26, 1998; 95(11): 6331 - 6336. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Oravecz, M. Pall, G. Roderiquez, M. D. Gorrell, M. Ditto, N. Y. Nguyen, R. Boykins, E. Unsworth, and M. A. Norcross Regulation of the Receptor Specificity and Function of the Chemokine RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) by Dipeptidyl Peptidase IV (CD26)-mediated Cleavage J. Exp. Med., December 1, 1997; 186(11): 1865 - 1872. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Pauly, F. Rosche, M. Wermann, C. H.S. McIntosh, R. A. Pederson, and H.-U. Demuth Investigation of Glucose-dependent Insulinotropic Polypeptide(1-42) and Glucagon-like Peptide-1-(7-36) Degradation in Vitro by Dipeptidyl Peptidase IV Using Matrix-assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry. A NOVEL KINETIC APPROACH J. Biol. Chem., September 20, 1996; 271(38): 23222 - 23229. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Tang, T. M. Gunn, D. F. McLaughlin, G. S. Barsh, S. F. Schlossman, and J. S. Duke-Cohan Secreted and membrane attractin result from alternative splicing of the human ATRN gene PNAS, May 23, 2000; 97(11): 6025 - 6030. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |